About Our Lab

The Bunyavanich Lab combines tools in epidemiology, multi-omics, and systems biology to study asthma and allergic diseases in human cohorts. Our goal is to better understand and identify risk factors, mechanisms, and potential therapies for these disorders. We are based at the Department of Genetics and Genomic Sciences and Department of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York, NY. We also contribute research as a member of NIH-funded asthma and allergy research networks.

Supinda Bunyavanich, MD, MPH, MPhil

Mount Sinai Endowed Professor in Allergy & Systems Biology
Associate Director, Jaffe Food Allergy Institute
Icahn School of Medicine at Mount Sinai, New York, NY 10029

Publication Highlights

Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. Bunyavanich S, Do A, Vicencio A. JAMA, 2020 May 20; 323(23):2427-9.

Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactions. Watson C, Cohain A, et al., Schadt E, Bunyavanich S. Nature Communications, 2017 Dec; 8(1):1943.

Merged Affinity Network Association Clustering: Joint multi-omic/clinical clustering to identify disease endotypes. Tyler S, Chun Y, Ribeiro V, Grishina G, Grishin A, Hoffman G, Do A, Bunyavanich S. Cell Reports. 2021 Apr 13;35(2):108975.

Machine learning-driven identification of early-life air toxic combinations associated with childhood asthma outcomes.
Li Y, Hsu H, Chun Y, Chiu P, Arditi Z, Claudio L, Pandey G, Bunyavanich S. Journal of Clinical Investigation. 2021 Nov 15;131(22):e152088.